lec 17/18: ethical, religious and political debate around stem cells

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/20

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

21 Terms

1
New cards

what is the common public misconception/view around stem cells?

2
New cards

how do reports describe stem cell therapy time line? how does this differ from actuality?

3
New cards

describe the different views of the moral status of the embryo

4
New cards

describe the different religious views around the used of embryos in stem cell research

5
New cards

describe the validity of stem cell preservation/bank claims

6
New cards

how do high-profile individuals influence stem cell therapy views

7
New cards

describe how the concept of medical tourism relates to stem cells

8
New cards

when are people most willing to consider stem cell therapies?

9
New cards

what tissue types are often preserved in banks? are these useful?

10
New cards

how are stem cells advertised in cosmetics? is there truth to this?

11
New cards

describe some of the uses of stem cells for animals

  • are there concerns around these?

12
New cards

describe the examples of cloning pets

13
New cards

how does pet cloning target their consumers?

14
New cards

explain the moral dilemma around using stem cells to save endangered species

15
New cards

describe the case of bringing back mammoths

16
New cards

how do stem cells relate to economics?

knowt flashcard image
17
New cards

what is translational medicine

18
New cards

describe the cost of stem cell therapy research and how the cost is expected to change

19
New cards

when can the strict legislation around drug and therapy approval be waived?

20
New cards

describe the FDA approval process from bench to bedside and how the two exemptions can skip phases

21
New cards

describe two cases in which the FDA had to take legal action